The Brighterside of News on MSN
Experimental drug can sharply reduce amyloid beta's impact on Alzheimer’s
Early in Alzheimer’s disease, your brain can begin to change long before anyone notices a lost name or missed appointment.
Neurodegenerative diseases, traditionally viewed as driven by neuronal decline, are increasingly recognized to involve ...
Published in Volume 1 of the journal Immunity & Inflammation on December 18, 2025, the article "Reinventing brain immunity in neurodegeneration ...
A 30% calorie reduction over decades slows brain aging in monkeys by preserving microglia and oligodendrocytes, new research ...
The Brighterside of News on MSN
Silent spinal cord cells may hold the key to healing after devastating injuries and brain disease
Silent cells deep in your spinal cord may hold a surprising key to healing after devastating injuries and brain disease. A ...
New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early ...
Summary: Researchers have created a new experimental model that reveals how changing a key Alzheimer’s risk gene can shift ...
Growing evidence suggests that the key to treating Alzheimer's is catching it in its earliest stages. Now scientists have developed a promising new drug that seems to be effective at stalling the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results